Background
==========

Pulmonary fibrosis (PF) is a serious interstitial lung disease characterized by distributive and progressive remodeling of the lung, with the formation of irreversible scars due to repetitive lung epithelial cell damage from harmful environmental factors and inherent genetic susceptibility \[[@b1-medscimonit-26-e922782]\]. Although previous studies indicated that PM2.5 (≤2.5 μm in aerodynamic diameter, PM2.5) is involved in the pathogenesis of various respiratory and cardiovascular diseases \[[@b2-medscimonit-26-e922782]--[@b4-medscimonit-26-e922782]\], whether PM2.5 can induce PF independently has not been well researched. A previous study indicated oxidative stress, inflammation, chemotaxis of monocytes/macrophages, epithelial mesenchymal transition (EMT), and abnormal activation or differentiation of lung fibroblasts are all involved in the development of PF \[[@b5-medscimonit-26-e922782]\]. Oxidative stress and inflammation are 2 major characteristics induced by PM2.5. Reactive oxygen species (ROS) produce oxidative stress and trigger the cell apoptosis and necrosis associated with PM2.5 exposure \[[@b6-medscimonit-26-e922782]\]. In addition, dysregulation of inflammatory mediators is closely associated with the progression of PM2.5-induced lung injury and PF \[[@b7-medscimonit-26-e922782]--[@b9-medscimonit-26-e922782]\]. TGF-β1 (transforming growth factor-β1) is also an extensively described pro-fibrosis factor that takes part in the onset and progression of PF by interacting with 2 specific receptors -- type I receptor (TGF-βRI) and type II receptor (TGF-βRII) \[[@b4-medscimonit-26-e922782]\] -- but the mechanisms underlying PM2.5-induced lung injury and PF are complicated and elusive. PF is an irreversible disease, for which treatment and prevention strategies are inadequate.

Extracellular vesicles (EVs, 20\~2000 nm) are important mediators of intercellular communications \[[@b10-medscimonit-26-e922782]--[@b13-medscimonit-26-e922782]\] and are generally classified into exosomes, microvesicles (MVs), and apoptotic bodies according to their origin, size, and content \[[@b14-medscimonit-26-e922782]\]. Exosomes and MVs are together often called EVs; they contain plasma membrane proteins such as tetraspanin (CD9, CD63, and CD81), lipid raft proteins (flotillin and caveolin-1), RNAs, and cytoplasmic proteins \[[@b15-medscimonit-26-e922782]\]. EVs are considered to have cellular functions similar to their mother cells \[[@b14-medscimonit-26-e922782],[@b16-medscimonit-26-e922782]\]. For instance, EVs originating from resting macrophages exert an anti-inflammatory effect, whereas those after LPS (lipopolysaccharide) stimulation have proinflammatory effects \[[@b17-medscimonit-26-e922782]\]. EVs are secreted by most cell types, including ADSCs (adipose mesenchymal stem cells), macrophages, dendritic cells, and epithelial cells. ADSCs are reported to be efficient mass producers of EVs \[[@b18-medscimonit-26-e922782]\] and these EVs are considered as potential therapeutic agents based on their antioxidative stress and anti-inflammation properties \[[@b19-medscimonit-26-e922782]--[@b21-medscimonit-26-e922782]\]. Therefore, we hypothesized that EVs released by ADSCs can mitigate PM2.5-induced lung injury and PF, and we performed relevant experiments to test this.

Material and Methods
====================

Antibodies and reagents
-----------------------

Antibodies against rat Nrf2, TGF-β1, TGF-βRII, TGF-βRI, β-actin, TSG101, CD63, Alix, GM130, and ELISA kit for TNF-α were obtained from Abcam PLC (MA, USA). DMEM, F12 nutrient medium, fetal bovine serum (FBS) without exosome, Trizol-LS, exosomal protein extraction kit, and Annexin V-FITC Apoptosis Kit were purchased from Invitrogen (Carlsbad, USA). qRT-PCR primers, let-7d-5p mimics, miR-NC, and let-7d-5p inhibitor were from Sangon Biotech (Shanghai, China). DCFH-DA and PKH67 green fluorescent cell linker mini-kit were obtained from Sigma Chemical Company (St. Louis, USA). The kit for bicinchoninic acid (BCA) protein assay was purchased from Beyotime Biotechnology (Shanghai, China).

PM2.5 collection and analysis
-----------------------------

PM2.5 samples were collected at Xinsi Road, Xi'an, China between January 2017 and December 2018. The collection method of PM2.5 in this study was based on a previous report \[[@b22-medscimonit-26-e922782]\]. The collected PM2.5 samples were filtrated by multi-layer sterile gauze. The filtrate was centrifuged at 4°C and 10 000 rpm for 20 min. The supernatant was oscillated by an ultrasonic oscillator and the particulate matter at the bottom was collected. Finally, the supernatant and collected particles were mixed and underwent vacuum freeze-drying. The samples were preserved at −80°C and diluted with PBS for later use.

PM2.5 morphology and size were assessed by scanning electron microscopy (SEM, Tokyo, Japan) according to the methods of a previous study \[[@b23-medscimonit-26-e922782]\].

Animals and cells culture
-------------------------

The animal experiments were performed on 6-week-old male Sprague-Dawley rats from the Experimental Animal Center of the Fourth Military Medical University (Xi'an, China). The animal experiments were approved by the Fourth Military Medical University Animal Care and Use Committee (approval no. 20190229).

Rat type II alveolar epithelial cells (ATII) were purchased from Shanghai Cell Institute Country Cell Bank (Shanghai, China) and placed in DMEM/F12 supplemented with 10% FBS and appropriate growth factors, at 37°C in an atmosphere of 5% CO~2~. ADSCs were primary cultured based on a previous report \[[@b24-medscimonit-26-e922782]\].

Extraction and identification of ADSCs-EVs
------------------------------------------

The EVs extraction process was performed according to previously described methods \[[@b25-medscimonit-26-e922782]\]. Transmission electron microscope (TEM) analysis of ADSCs-EVs was performed using the method of Li et al. \[[@b24-medscimonit-26-e922782]\]. The size and concentration of ADSCs-EVs were determined by Nanoparticle Tracking Analysis (Nanosight ns500, Malvern Instruments, UK). A size distribution plot was constructed, with the x-axis representing the particle diameter (nm) and the y-axis showing the particle percentage. Trizol-LS and an exosomal protein extraction kit were used to extract RNA and proteins from ADSCs-EVs, according to the manufacturer's instructions. ADSCs-EVs were stored at −80°C and used for subsequent experiments. Western blotting was performed to determine the expression levels of TSG101, Alix, GM130, and CD63 in EVs and cell lysates.

Uptake of ADSCs-EVs
-------------------

To determine whether ADSCs-EVs could be absorbed by cells, ADSCs-EVs (5×10^8^) were suspended in 0.5 mL diluent C. Then, 4 μL PKH67 was added into 0.5 mL diluent C and incubated at room temperature for 4 min. Next, 2 mL PBS was added to prevent excessive dyeing, and centrifugation of labeled ADSCs-EVs was performed for 1 h to eliminate the residual dyes. The suspended ADSCs-EVs were precipitated in 200 μL PBS at 4°C in the dark. The labeled ADSCs-EVs were added to the recipient cells (in a confocal culture dish, 1×10^6^ cells) and incubated at 37°C for 4 h in the dark. The cells were then washed 3 times with PBS. Then, 1 mL of fixative solution was added and the mixture was incubated in the dark for 10 min. Fixative fluid was removed, and the cells were washed 3 times with PBS for 2 min each time. Hoechst 33342 (500 μL, stain for the cell nucleus) was added and incubated for 5 min in the dark. Hoechst 33342 was removed and the cells were washed 3 times with PBS for 2 min each time. F-actin (100 μL; for staining of the cytoskeleton) was added and incubated in the dark for 30 min. The cells were then washed 3 times with PBS for 2 min each time. Finally, 1 mL of PBS was added into the confocal dish to prevent cell drying, and the dish was kept in the dark. Fluorescent photography of the control and experimental groups were performed by confocal microscopy (Olympus, Japan) the next day.

*In vivo* PM2.5 exposure and treatment of ADSCs-EVs
---------------------------------------------------

Rats were divided into 4 groups based on different treatments: "PBS" (none), "ADSCs-EVs+PBS", "PM2.5+PBS", or "PM2.5+ADSCs-EVs", with 5 rats in each group. Rats were intratracheally instilled with 20 μL concentrated PM2.5 (1.5 mg/kg/day) solution (PBS) 3 days a week (Monday, Wednesday, and Friday) for 4 weeks. The exposure dose of PM2.5 was based on a previous study \[[@b26-medscimonit-26-e922782]\]. Treatments of PBS or ADSCs-EVs (2.5\~2.8×10^10^ in 20 μL PBS) were administrated via intratracheal instillation at 1 h after PBS/PM2.5 exposure. The treatment dose of EVs was determined according to the study by Willis \[[@b27-medscimonit-26-e922782]\]. At 3, 6, 9, 12, and 24 h after single exposure or 24 h after the end of the 4-week exposure, the rats were anesthetized with pentobarbital sodium (40 mg/kg) and killed. Samples of lung tissue and bronchoalveolar lavage fluid (BALF) were collected for analysis according to a previously described method \[[@b6-medscimonit-26-e922782]\].

*In vitro* PM2.5 exposure and treatment of ADSCs-EVs
----------------------------------------------------

ATII cells (1×10^6^) were exposed to PBS, ADSCs-EVs (1×10^9^), PM2.5 (50 μg/mL), or PM2.5 (50 μg/mL) +ADSCs-EVs (1×10^9^, 1 h after the cells were exposed to PM2.5). Six hours later, apoptosis (Annexin V-FITC) was determined by flow cytometry analysis (Becton Dickinson and Company, USA) using a previously described method \[[@b24-medscimonit-26-e922782]\]. Proteins or RNAs were extracted from cells with different treatments for Western blotting and qRT-PCR analysis.

Staining analysis
-----------------

Hematoxylin-eosin (HE) staining and immunohistochemistry (IHC) staining analyses were performed as described by Li et al. \[[@b28-medscimonit-26-e922782]\]. Stained slides were assessed according to the staining intensity (strong: 3; moderate: 2; weak: 1; and negative: 0) and the abundance of positive cells (≤5%: 0; 6--25%: 1; 26--50%: 2; 51--75%: 3, and ≥76%: 4). A final score obtained from the intensity score multiplied by the extent score was used to identify various target expression levels.

Masson's trichrome staining was performed as previously described \[[@b29-medscimonit-26-e922782]\]. The relative collagenous fiber area was determined by use of Image J software. Immunofluorescence staining was performed as previously reported \[[@b30-medscimonit-26-e922782]\]. ROS staining \[[@b31-medscimonit-26-e922782]\] and TEM assay \[[@b6-medscimonit-26-e922782]\] were performed as previously reported.

Luciferase activity assay
-------------------------

ATII cells were transfected with 50 pmol of miR-NC or let-7d-5p. The next day, the cells were transfected with 0.2 μg of the psiCHECK2 vector (Promega, Madison, USA) expressing the 3′ UTR of the rat TGF-βRI mRNA or the mutated 3′ UTR of the TGF-βRI mRNA (Quik Change II Site-Directed Mutagenesis Kit, Agilent, USA) with JETPEI (Polyplus transfection) according to the manufacturer's instructions. After 24 h, the luciferase assay was performed using the Dual-Luciferase Reporter Assay System (Promega).

qRT-PCR analysis and Western blotting
-------------------------------------

The cells or EVs were resuspended in Trizol-LS and total RNA was extracted and reverse transcribed according to the manufacturer's instructions. The sequence for rat let-7d-5p, miR-98-5p, and let-7i-5p are shown in [Table 1](#t1-medscimonit-26-e922782){ref-type="table"}.

For Western blot analysis, proteins were extracted from the cells via lysis buffer (with 1% PMSF and phosphatase inhibitor) on ice for 20 min. Samples were then centrifuged at 12 000 g and 4°C for 20 min, then the supernatant was collected for further assay. Samples containing 40 μg of proteins were loaded onto a 10% sodium dodecyl sulfate (SDS)-PAGE gel and electrophoretically transferred to polyvinylidene fluoride membranes. Then, primary antibodies were added and incubated overnight with the membrane at 4°C. After washing with TBST 3 times, membranes were incubated with Anti-rabbit Ig G secondary fluorescent antibody (CST, Beverly, USA) for 1 h in the dark. The membranes were then washed 3 times with TBST. Antibody-bound membranes were examined by using the Li-Cor Odyssey system (Li-Cor Biosciences).

Statistical analysis
--------------------

Mean±standard deviation (SD) were used to express results. Each variable for differences among the different groups were tested by *t* test and one- or two-way analysis of variance (ANOVA). *P*\<0.05 was considered to indicate statistical significance. All data shown are representative of experiments conducted at least 3 times.

Results
=======

Rats exposed to PM2.5 developed lung injury and PF
--------------------------------------------------

The morphology of PM2.5 is shown in [Figure 1A](#f1-medscimonit-26-e922782){ref-type="fig"} and size analysis of PM2.5 is shown in [Figure 1B](#f1-medscimonit-26-e922782){ref-type="fig"}. HE staining showed that 6 h after single exposure to PM2.5, the lungs developed acute pathological changes, including alveolar congestion, hemorrhage, edema, and alveolar destruction ([Figure 1C](#f1-medscimonit-26-e922782){ref-type="fig"}), and exposure to PM2.5 elevated levels of ROS, TGF-β1, and inflammatory factor (TNF-α) in BALF ([Figure 1D](#f1-medscimonit-26-e922782){ref-type="fig"}). TEM results showed that after exposure to PM2.5, the "villous-like" surfactant coating of normal type II alveolar epithelial cells was eliminated and the number of impaired lamellar bodies increased ([Figure 1E](#f1-medscimonit-26-e922782){ref-type="fig"}), suggesting the functional impairment of type II alveolar epithelial cells. These findings indicate that single PM2.5 exposure can cause serious lung injury. Further, we observed that long-term (4 weeks) PM2.5 exposure led to obviously fibrotic changes in the lung, accompanied with an increase of TGF-β1 ([Figure 1F, 1G](#f1-medscimonit-26-e922782){ref-type="fig"}).

ADSCs-EVs alleviated PM2.5-induced lung injury and PF in rats
-------------------------------------------------------------

Rat ADSCs were identified through their multilineage differentiation ability ([Figure 2A](#f2-medscimonit-26-e922782){ref-type="fig"}). ATII cells were identified through anti-SP-C immunofluorescence staining ([Figure 2B](#f2-medscimonit-26-e922782){ref-type="fig"}). EVs derived from ADSCs were collected and analyzed. TEM ([Figure 3A](#f3-medscimonit-26-e922782){ref-type="fig"}) and NTA ([Figure 3B](#f3-medscimonit-26-e922782){ref-type="fig"}) analyses revealed a heterogeneous population of ADSCs-EVs, which had a typical diameter of 170 nm and exhibited distinct biconcave morphological feature. The expressions of GM130, Alix, TSG101, and CD63 of ADSCs-EVs were detected by Western blotting ([Figure 3C](#f3-medscimonit-26-e922782){ref-type="fig"}).

We performed *in vitro* experiments to determine the protective effects of ADSCs-EVs on PM2.5-exposed ATII cells. Using laser scanning confocal microscopy, we observed ADSCs-EVs were taken up by ATII cells ([Figure 3D](#f3-medscimonit-26-e922782){ref-type="fig"}). Apoptosis assay indicated that PM2.5 exposure resulted in early and late apoptosis or necrosis in ATII cells. ADSCs-EVs treatment considerably decreased the apoptosis or necrosis ([Figure 3E](#f3-medscimonit-26-e922782){ref-type="fig"}). Further, the protective effects of ADSCs-EVs on PM2.5-induced lung injury *in vivo* was evaluated after the rats were exposed to PM2.5, ADSCs-EVs, or PM2.5+ADSCs-EVs 1 time. We found that PM2.5 could induce high production of ROS in BALF, and this upregulation was suppressed by ADSCs-EVs treatment ([Figure 3F](#f3-medscimonit-26-e922782){ref-type="fig"}). Similarly, inflammation factor (TNF-α) in BALF was also repressed by ADSCs-EVs ([Figure 3G](#f3-medscimonit-26-e922782){ref-type="fig"}). HE staining results showed that the ADSCs-EVs reduced the levels of alveolar congestion, hemorrhage, edema, and alveolar destruction induce by PM2.5 ([Figure 3H](#f3-medscimonit-26-e922782){ref-type="fig"}). Taken together, these results suggest that ADSCs-EVs could serve as efficient antioxidative and anti-inflammatory interventions and further protect rats from lung injury induced by PM2.5.

To investigate the effect of ADSCs-EVs on PF induced by PM2.5, we established long-term PM2.5 exposure models in rats and treated the rats with or without ADSCs-EVs. PF level was evaluated by Masson staining and quantified based on the collagenous fiber area. The results indicated that rats exposed to PM2.5 (4 weeks) showed more obvious PF compared with those exposed to PBS, but the PM2.5-exposed rats treated with ADSCs-EVs showed less PF (*p*\<0.01) than those that were not treated ([Figure 4](#f4-medscimonit-26-e922782){ref-type="fig"}). The levels of pro-fibrosis factors TGF-β1, TGF-βRI, and TGF-βRII were measured by IHC staining or IF staining. The results suggested that PM2.5 induced high expression of these cytokines. TGF-βRI was obviously repressed after ADSCs-EVs treatment (*p*\<0.01), but this was not observed for TGF-β1 and TGF-βRII. Compared with the normal rats, the rats treated with ADSCs-EVs for 4 weeks showed no obvious alterations in lungs, which suggests that ADSCs-EVs had no obvious negative effects on the lungs.

ADSCs-EVs suppressed PF by inhibition of TGF-βRI by transferring let-7d-5p
--------------------------------------------------------------------------

Previous results indicated that ADSCs-EVs mitigated PM2.5-induced PF. To further define the underlying mechanism of the anti-fibrosis effect of ADSCs-EVs, we then tested pro-fibrosis cytokines associated with the TGF-β1 pathway (TGF-βRI and TGF-βRII) in ATII cells exposed to different treatments *in vitro* by Western blot analysis ([Figure 5A](#f5-medscimonit-26-e922782){ref-type="fig"}). Consistent with our *in vivo* experiment results, Western blot analysis indicted that TGF-βRI was remarkably downregulated in PM2.5-exposed ATII cells following treatment with ADSCs-EVs (*p*\<0.05). Given that TGF-β1 induced PF by activation of Smad2/3 through combination with TGF-βRI and TGF-βRII \[[@b32-medscimonit-26-e922782]\], the regulation of TGF-βRI was critical in the relief of PF. Therefore, we mainly focused on the effect of ADSCs-EVs on the expression of TGF-βRI in recipient cells and the underlying mechanisms.

miRNAs are known to exert their regulatory effects on protein expression, which suggests that the exosomal delivery of miRNAs could be a novel mechanism for intercellular communication. We hypothesized that ADSCs-EVs repressed the expression of TGF-βRI by delivering upstream miRNAs into recipient cells. Therefore, we utilized 3 miRNA target-predicting algorithms (miRTarBase, miRDB and TargetScan) to identify the potential upstream targets of TGF-βRI, and 3 miRNAs were identified (let-7d-5p, miR-98-5p, and let-7i-5p). First, we measured levels of these miRNAs in ATII cells treated with PBS, PM2.5, or PM2.5+ADSCs-EVs. The results indicated that treatment of ADSCs-EVs significantly increased the let-7d-5p level in ATII cells ([Figure 5B](#f5-medscimonit-26-e922782){ref-type="fig"}), but this effect of ADSCs-EVs was not observed with miR-98-5p and let-7i-5p. Western blot analysis ([Figure 6A](#f6-medscimonit-26-e922782){ref-type="fig"}) suggested that PM2.5-induced high expression of TGF-βRI could be downregulated by ADSCs-EVs as well as by let-7d-5p mimics. qRT-PCR analysis further indicated that the upregulation of TGF-βRI mRNA induced by PM2.5 was suppressed by ADSCs-EVs and let-7d-5p mimics ([Figure 6B](#f6-medscimonit-26-e922782){ref-type="fig"}). Consistently, let-7d-5p inhibitor rescued the reduction of TGF-βRI mRNA induced by ADSCs-EVs, which suggested that ADSCs-EVs-induced TGF-βRI downregulation was potentially mediated by let-7d-5p. Luciferase assay ([Figure 6C, 6D](#f6-medscimonit-26-e922782){ref-type="fig"}) further confirmed that the reporter activity was significantly reduced after co-transfection with psiCHECK2-TGF-βRI-wt-3′UTR and let-7d-5p mimics (p\<0.01), compared with cells co-transfected with psiCHECK2-TGF-βRI-mt-3′UTR and let-7d-5p mimics, suggesting that TGF-βRI is a direct target gene of let-7d-5p. Taken together, these observations suggest that ADSCs-EVs inhibited the expression of TGF-βRI by transferring let-7d-5p.

Discussion
==========

We found that exposure to PM2.5 initially caused lung injury, including morphological alterations, oxidative stress, and inflammation, and then gradually led to PF. ADSCs-EVs protected lungs from the effects of PM2.5 exposure. Our findings show that ADSCs-EVs can mitigate PM2.5-induced PF via inhibiting TGF-βRI by transferring let-7d-5p.

The lungs are the major targets for most air-borne particles. Evidence indicates that an increase in the concentration of PM2.5 is related to elevated morbidities of pulmonary or cardiovascular diseases \[[@b6-medscimonit-26-e922782]\]. Excessive production of ROS and inflammatory cytokines are the key causes of PM2.5-induced cytotoxicity, which are the triggers of apoptosis, necrosis, lung injury, or pro-fibrosis changes \[[@b33-medscimonit-26-e922782]\]. It is still unclear which parts or factors of PM2.5 play key roles in inducing ROS and inflammation. Several studies have shown that carbonaceous materials, metals, and PAHs can all individually cause ROS and inflammation \[[@b34-medscimonit-26-e922782]\]. Our study shows that PM2.5 induces obvious oxidative stress and inflammation. The suppression of ROS or inflammation by ADSCs-EVs contributes to the viability of cells and relieves lung injury and PF. Similar findings were previously reported in kidney injury \[[@b35-medscimonit-26-e922782]\], and our study verifies these effects in the lungs.

Mesenchymal stem cells (MSCs) are multipotent, nonhematopoietic adult stem cells that contain bone marrow mesenchymal stem cells (BMSCs), umbilical cord mesenchymal stem cells (UMSCs), placenta mesenchymal stem cells (PMSCs), and ADSCs \[[@b36-medscimonit-26-e922782]\]. ADSCs have been widely used for EVs collection, mostly because they are readily available and relatively stable \[[@b18-medscimonit-26-e922782]\]. EVs derived from MSCs have been reported to be efficient carriers for proteins or RNAs delivery, especially miRNAs \[[@b36-medscimonit-26-e922782]\]. Some miRNAs, such as let-7c, miR-21, and miR-192, have been reported to be involved in fibrosis via regulation of the TGF-β signaling pathway \[[@b37-medscimonit-26-e922782]\]. TGF-β1 is extensively reported to take part in the onset and progression of PF \[[@b4-medscimonit-26-e922782],[@b37-medscimonit-26-e922782]\]. All TGF-β isoforms bind to TGF-βRII as homodimers (their active form); TGF-βRII then recruits and activates TGF-βRI \[[@b38-medscimonit-26-e922782]\]. TGF-βRI kinase subsequently activates downstream signaling by phosphorylating Smad2 and Smad3, which oligomerize with Smad4 and then translocate to the nucleus to regulate pro-fibrosis gene expression \[[@b32-medscimonit-26-e922782]\]. TGF-βRI, also known as ALK5, can also activate a wide variety of Smad-independent pathways (known as noncanonical signaling) to modify cell function \[[@b37-medscimonit-26-e922782]\]. Our work is the first to demonstrate that ADSCs-derived EVs can suppress TGF-βRI induced by PM2.5 through transferring let-7d-5p into recipient cells, thus relieving pulmonary fibrosis. The enrichment of let-7 family miRNAs in EVs derived from MSCs has been previously reported, suggesting a new treatment based on EVs to attenuate renal fibrosis \[[@b39-medscimonit-26-e922782]\]. Thereby, the anti-fibrosis effect of MSCs-EVs has been validated in different organs.

Therapy based on MSCs-EVs has become an important research focus in many areas. For instance, Willis et al. suggested that EVs derived from MSCs can reduce the severity of experimental bronchopulmonary dysplasia and restore lung function via immunomodulatory effects on macrophages \[[@b27-medscimonit-26-e922782]\]. Li et al. reported that EVs from ADSCs could be used to promote wound healing in diabetic foot ulcers \[[@b24-medscimonit-26-e922782]\]. Based on our findings and relevant studies, we infer that the possible mechanisms underlying the therapeutic effects of EVs are as follows: EV-encapsulating proteins or RNAs are resistant to proteases or RNases, which gives EVs good stability in the circulation when traversing long distances within the body, under both physiological and pathological conditions \[[@b40-medscimonit-26-e922782],[@b41-medscimonit-26-e922782]\]. Therefore, EVs are a consistent source of protein, mRNA, or miRNAs for targeted delivery and for use as a biomarker with low immunogenicity and antigenicity. MSCs can induce expression of anti-inflammatory-tolerant phenotypes of various cells and the immunomodulatory properties of MSCs are also observed in their EVs \[[@b42-medscimonit-26-e922782]\].

Conclusions
===========

We find that EVs derived from ADSCs can exert protective effects against PM2.5-induced lung injury and PF, and also provides a strategy for the further application of EVs in relieving lung disease associated with environmental pollution.
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![PM2.5 exposure induced lung injury and PF. (**A**) SEM image of PM2.5. (**B**) Particles size distribution of PM2.5. (**C**) HE staining of lungs at 6 h after single exposure to PBS (None) or PM2.5. (**D**) Relative ROS of cells, TGF-β1 and TNF-α concentrations in BALF at different time points (3, 6, 9, 12, and 24 h after PM2.5 single exposure) were detected. (**E**) TEM of type II alveolar epithelial cells 6 hours after rats were treated with PBS (None) or PM2.5. (**F**) Masson staining of lung tissues with treatments of PBS or PM2.5 for 4 weeks (Yellow arrows represented PF). (**G**) IHC staining of TGF-β1 in lungs after treatments of PBS or PM2.5 for 4 weeks. (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001).](medscimonit-26-e922782-g001){#f1-medscimonit-26-e922782}

![The identification of ADSCs and AT II cells. (**A**) Multilineage differentiation of ADSCs (**upper left:** osteoblast differentiation, **upper middle:** adipocyte differentiation, **upper right:** cartilage differentiation) and typical image of ADSCs (**lower**). (**B**) SP-C immunofluorescence staining for AT II cells.](medscimonit-26-e922782-g002){#f2-medscimonit-26-e922782}

![ADSCs-EVs alleviated lung injury induced by PM2.5. (**A**) TEM identification of ADSCs-EVs. (**B**) NTA analysis of ADSCs-EVs. (**C**) GM130, Alix, TSG101, and CD63 expressions in ADSCs-EVs and cell lysates were detected by Western blotting. (**D**) The uptake of ADSCs-EVs in ATII cells was detected by a confocal microscopy. (**E**) Apoptosis or necrosis of ATII cells with treatments of PBS (None), ADSCs-EVs, PM2.5, or PM2.5+ADSCs-EVs was detected by flow cytometry assay. (**F**) Six hours after the rats treated with PBS (None), ADSCs-EVs, PM2.5 or PM2.5+ADSCs-EVs, relative ROS level in BALF was measured. (**G**) Six hours after the rats treated with PBS (None), ADSCs-EVs, PM2.5, or PM2.5+ADSCs-EVs, TNF-α concentration in BALF was evaluated. (**H**) HE staining of lungs exposed to PBS (None), ADSCs-EVs, PM2.5 or PM2.5+ADSCs-EVs. (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001).](medscimonit-26-e922782-g003){#f3-medscimonit-26-e922782}

![ADSCs-EVs alleviated PF induced by PM2.5. Masson staining, IHC staining for TGF-β1, IF staining for TGF-βRI and TGF-βRII in lungs exposed to PBS (None), ADSCs-EVs, PM2.5, or PM2.5+ADSCs-EVs for 4 weeks. (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001).](medscimonit-26-e922782-g004){#f4-medscimonit-26-e922782}

![ADSCs-EVs repressed TGF-βRI expression. (**A**) Western blotting analysis of TGF-β1, TGF-βRI, and TGF-βRII levels in ATII cells under different treatments. (**B**) The miRNA levels in ATII cells with different treatments were measured by qRT-PCR. (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001).](medscimonit-26-e922782-g005){#f5-medscimonit-26-e922782}

![let-7d-5p directly inhibited the expression of TGF-βRI. (**A**) The expression of TGF-βRI under different treatments was tested by Western blotting. (**B**) The expression of TGF-βRI mRNA under different treatments was tested by qRT-PCR. (**C**) Schematic representation of matching sequence between TGF-βRI 3′UTR mRNA and let-7d-5p. (**D**) Luciferase activity of ATII cells co-transfected with reporter plasmid ("TGF-βRI wt" or "TGF-βRI mt") and let-7d-5p or miRNA-NC. (\* p\<0.05; \*\* p\<0.01; \*\*\* p\<0.001).](medscimonit-26-e922782-g006){#f6-medscimonit-26-e922782}

###### 

Primer sets for qRT-PCR.

  miRNAs      Sequence (F)
  ----------- -----------------------------
  let-7d-5p   CGCCAGAGGTAGTAGGTTGCATAGTT
  miR-98-5p   CGCGCCTGAGGTAGTAAGTTGTATTGT
  let-7i-5p   CGCTGAGGTAGTAGTTTGTGCTGTT
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